Lutz, R. Max Planck Institute of Psychiatry, Max Planck Society;
Lutz, R., Köhnlein, O., Minov, C., Vogel, M., Eichinger, M., Messer, T., et al. (2003). Management of the atypical antipsychotic Olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State Hospital. Pharmacopsychiatry, 36(5), 245-246.